↓ Skip to main content

Who can benefit from postmastectomy radiotherapy among HR+/HER2- T1-2 N1M0 breast cancer patients? An explainable machine learning mortality prediction based approach

Overview of attention for article published in Frontiers in endocrinology, February 2024
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
7 Mendeley